Patients identified with a disease-causing change (a pathogenic or likely pathogenic varient) in a gene on this panel have an increased risk of developing the associated neurodegenerative disease. Genetic testing may be beneficial in the planning and decision-making process for treatment, psychological counseling, research study enrollment and support programs for caregivers and patients. Your patient’s family members should be tested to better help define their risk(s) as well. If a pathogenic variable is identified in your patient, close relatives (children, siblings, and parents) are up to 50% more likely to be at an increased risk.